CenterWatch Revamps the Clinical Trials Listing Service for Patients

Article

Company News Release

CenterWatch, a leading publisher of clinical trials information for patients and professionals, announced today that it has launched a revamped version of its award-winning Clinical Trials Listing Service (CTLS) to better serve the public and patient communities.

CenterWatch

, a leading publisher of clinical trials information for patients and professionals, announced today that it has launched a revamped version of its award-winning

Clinical Trials Listing Service

(CTLS) to better serve the public and patient communities.

The new CTLS™ presents the largest international listing of phase I – IV clinical trials actively recruiting volunteers in simpler language, improved format, more advanced search capabilities and better navigation. CenterWatch solicited extensive feedback from patients to guide and direct the revamp effort.

“Patients and their advocates have long complained that online clinical trial registries and listings are too technical, difficult to understand and of questionable quality,” said Niki Eastley, CenterWatch’s senior manager of Internet Operations and Development. “We’re so pleased to make these enhancements with the patient at the center of our revamp efforts.”

As an independent publisher, CenterWatch’s clinical trial listing service aggregates information from a variety of sources including directly from research sponsors and from investigative sites making the CTLS™ the largest and most comprehensive listing of industry-funded clinical trials on the web today.

“We apply our editorial and quality standards to the listings in the CenterWatch service,” said Joan Chambers, Chief Operating Officer. “Most web sites show a small number of trials of variable quality. The CTLS™ is the go-to destination by patients and their advocates for the largest, highest quality, easiest-to-use clinical trial information available.”

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.